Sinus Clear
- Manufacturer
- Apotheca Company
- Effective date
- 2011-02-25
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:04
Label at a glance#
ProductSinus Clear
Active ingredientCALCIUM SULFIDE, POTASSIUM DICHROMATE, PULSATILLA VULGARIS, SILICON DIOXIDE
Label structure9 sections
Contacts and useful links#
Websitewww.ridgecrestherbals.com
www.ridgecrestherbals.com
www.ridgecrestherbals.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Hepar sulphuris calcareum 10X, Kali bichromicum 10X, Pulsatilla 10X, Silicea 10X.
OTC - PURPOSE SECTION
SINUS CLEAR is a carefully formulated homeopathic remedy which effectively relieves nasal congestion and restores free breathing through the nose. Sinus Clear is non-drowsy and produces no side effects.
WARNINGS SECTION
WARNINGS: If symptoms do not improve or are accompanied by a fever, consult a doctor. If you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.
Keep this and all other medicines out of the reach of children.
Do not use if tamper resistant seal is broken.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Adults and children 12 and over take 1 capsule 3 times daily before meals.
INACTIVE INGREDIENT SECTION
OTHER INGREDIENTS: Chinese cimicifuga root, Chinese locorice root, Chinese lovage root, cnidium root, Fragrant angelica root, Green tea leaf, Magnolia flower, Notopterygium root, Psyllium seed, Siler root, Xanthium fruit, Microcrystalline cellulose, Cellulose capsule.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP THIS AND ALL OTHER MEDICINES OUT OF THE REACH OF CHILDREN.
INDICATIONS & USAGE SECTION
SINUS CLEAR is a carefully formulated homeopathic remedy which effectively relieves nasal congestion and restores free breathing through the nose. Sinus Clear is non-drowsy and produces no side effects.
OTC - QUESTIONS SECTION
Manufactured for:
RidgeCrest Herbals, Inc.
3683 West 2270 South, Ste A
Salt Lake City, UT 84120-2306
phone: 1-800-242-4649
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
RIDGECREST HERBALS
Sinus Clear
Homeopathic/Herbal Nasal Decongestant
30 Capsules
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0133-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0532-f424-e053-dadaa90a57ce | Sinus Clear |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57520-0133-1 | Sinus Clear | 30 in 1 BOTTLE | CAPSULE | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57520-0133 | SINUS CLEAR (HEPAR SULPHURIS CALCAREUM, KALI BICHROMICUM, PULSATILLA, SILICEA,) CAPSULE [APOTHECA COMPANY] | 1 | Legacy NDC, 1 package rows | 20110301_de3a13a5-38d7-4f40-a986-c0ad9853a382.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM SULFIDE | ACTIVE INGREDIENT | 1MBW07J51Q | 1 | |
| POTASSIUM DICHROMATE | ACTIVE INGREDIENT | T4423S18FM | 1 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 1 | |
| SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| ACTAEA CIMICIFUGA ROOT | INACTIVE INGREDIENT | 65J267BAZT | 1 | |
| ANGELICA DAHURICA ROOT | INACTIVE INGREDIENT | 1V63N2S972 | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| CNIDIUM ROOT | INACTIVE INGREDIENT | 8S3OZD358J | 1 | |
| GREEN TEA LEAF | INACTIVE INGREDIENT | W2ZU1RY8B0 | 1 | |
| LICORICE | INACTIVE INGREDIENT | 61ZBX54883 | 1 | |
| LIGUSTICUM SINENSE ROOT | INACTIVE INGREDIENT | 32SLT970XO | 1 | |
| MAGNOLIA GRANDIFLORA FLOWER | INACTIVE INGREDIENT | RV23PE6426 | 1 | |
| NOTOPTERYGIUM FRANCHETII ROOT | INACTIVE INGREDIENT | KRT28P6ITK | 1 | |
| PLANTAGO SEED | INACTIVE INGREDIENT | 9C60Y73166 | 1 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | 1 | |
| SAPOSHNIKOVIA DIVARICATA ROOT | INACTIVE INGREDIENT | 8H84LFK2QD | 1 | |
| XANTHIUM | INACTIVE INGREDIENT | 8555ORT735 | 1 |
Products#
Every source-derived product name is available through these pages.
- Sinus Clear
- Hepar sulphuris calcareum, Kali bichromicum, Pulsatilla, Silicea,
- CALCIUM SULFIDE
- CALCIUM CATION
- POTASSIUM DICHROMATE
- POTASSIUM CATION
- PULSATILLA VULGARIS
- SILICON DIOXIDE
- ACTAEA CIMICIFUGA ROOT
- LICORICE
- CNIDIUM ROOT
- ANGELICA DAHURICA ROOT
- GREEN TEA LEAF
- MAGNOLIA GRANDIFLORA FLOWER
- NOTOPTERYGIUM FRANCHETII ROOT
- PLANTAGO SEED
- SAPOSHNIKOVIA DIVARICATA ROOT
- XANTHIUM
- CELLULOSE, MICROCRYSTALLINE
- POWDERED CELLULOSE
- LIGUSTICUM SINENSE ROOT
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0133 | 57520-0133-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | PASTE, DENTIFRICE / DENTAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | CAPSULE / ORAL | 2430 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DISC / TOPICAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | POWDER, FOR SUSPENSION / ORAL | 1600 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, FILM COATED / ORAL | 392 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, DELAYED RELEASE / ORAL | 16 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, CHEWABLE / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE / ORAL | 29520 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / SUBLINGUAL | 4.5 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | SUSPENSION / ORAL | 1600 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | LIQUID / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DISC / EXTRACORPOREAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / BUCCAL | 4.5 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DROPS / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION / ORAL | 1600 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c0e34435-7ef4-409a-897a-076f81d44240 | de3a13a5-38d7-4f40-a986-c0ad9853a382 | 2011-02-25 | Warnings | c0e34435-7ef4-409a-897a-076f81d44240 de3a13a5-38d7-4f40-a986-c0ad9853a382 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.